New PerioLase from Millennium Dental Receives FDA Clearance

Millennium Dental Technologies has been granted FDA clearance to market its revolutionary PerioLase(R) dental laser for gingival incision and excision and laser curettage (removal of diseased or inflamed soft tissue in the periodontal pocket), according to company founders Delwin K. McCarthy, D.D.S. and Robert H. Gregg II, D.D.S.
Designed by clinicians for clinicians, the PerioLase(R)
demystifies the dental laser, providing a breakthrough treatment for gum disease with a proprietary procedure called Laser Periodontal Therapy(TM). "LPT(TM) is a patient- and practitioner-friendly alternative to traditional surgery. It's the first periodontal procedure ever granted a patent and the only stand alone procedure that cost-justifies the purchase of a laser," notes Dr. McCarthy.
According to the Centers for Disease Control, 60% of the
population has moderate to severe gum disease, but fewer than 3% receive treatment. "Periodontal surgery is invasive. It's not
something patients readily accept," says Dr. Gregg. "But the
PerioLase(R) and LPT(TM) make treatment as easy as wiping chalk off a blackboard. LPT(TM) can be done in any general or specialty setting. There's no cutting of flaps, no sutures and a minimum of bleeding." Preservation of original gum tissue is maximized, so appearances are preserved and root exposure and increased sensitivity are avoided.
Other patient-friendly benefits such as 50% less chair time, lower cost, quicker recovery and almost no time lost from work give this procedure tremendous practice-building potential. "In 2001, optometrists performed 1.5 million Lasik procedures. We believe PerioLase(R) will have the same kind of patient appeal," adds Gregg.

Millennium Dental Technologies, Inc., can be reached at
888-49-LASER or www.millenniumdental.com.